BAY-u 9773

• CAT Number: I013999
• CAS Number: 154978-38-8
• Molecular Formula: C27H36O5S
• Molecular Weight: 472.60
• Purity: ≥95%
• Synonyms: 4-(((4S,5R,6E,8E,10E,13E)-1-carboxy-4-hydroxynonadeca-6,8,10,13-tetraen-5-yl)thio)benzoic acid;BAY-u 9773
• Target: Leukotriene Receptor
• Solubility: Soluble in ethanol (supplied pre-dissolved in Ethanol, 0.1mg/ml)
• Storage: Store at -80C
• IUPAC Name: 4-[(4S,5R,6E,8E,10Z,13Z)-1-carboxy-4-hydroxynonadeca-6,8,10,13-tetraen-5-yl]sulfanylbenzoic acid
• InChI: InChI=1S/C27H36O5S/c1-2-3-4-5-6-7-8-9-10-11-12-13-16-25(24(28)15-14-17-26(29)30)33-23-20-18-22(19-21-23)27(31)32/h6-7,9-13,16,18-21,24-25,28H,2-5,8,14-15,17H2,1H3,(H,29,30)(H,31,32)/b7-6-,10-9-,12-11+,16-13+/t24-,25+/m0/s1
• InChIKey: PKJINWOACFYDQN-RBVMPENBSA-N
• SMILES: CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@H](CCCC(=O)O)O)SC1=CC=C(C=C1)C(=O)O

BAY-u 9773（Cat No.:I013999）is a compound under investigation for its potential therapeutic applications, particularly in cancer treatment. It is known to be a selective inhibitor of the protein kinase CK2 (casein kinase 2), which plays a role in regulating cell growth, survival, and proliferation. By targeting CK2, BAY-u 9773 has shown potential in disrupting cancer cell signaling, offering a possible strategy for inhibiting tumor growth. This compound is still in research phases, with ongoing studies examining its efficacy, safety, and potential use in combination with other cancer therapies.